Clinical Trials Logo

Filter by:
NCT ID: NCT02667977 Withdrawn - Hyponatremia Clinical Trials

Reexamining Hypotonic Intravenous Fluid Use

Start date: October 2014
Phase: N/A
Study type: Interventional

The study aim is to isolate a single type of patient (pediatric patient with acute gastrointestinal symptoms) and evaluate the use of hypotonic (0.45 NS) vs. isotonic (0.9 NS) fluids in these patients in regards to changes in their serum sodium and iatrogenic hyponatremia.

NCT ID: NCT02667496 Withdrawn - Clinical trials for Dementia Alzheimer's Type

Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Start date: November 2016
Phase: Phase 2
Study type: Interventional

Primary Objective: To compare the effect of repeat doses of Leukine to placebo administered subcutaneously (SC) on established cortical amyloid load in patients with mild cognitive impairment (MCI) due to Alzheimer's disease (AD). Secondary Objective: - To evaluate safety and tolerability of Leukine versus placebo. - To explore the effect of Leukine versus placebo on cognitive performance. - To collect biospecimens for future biomarker research.

NCT ID: NCT02666729 Withdrawn - Atrial Fibrillation Clinical Trials

Use of a Novel Contact Force Sensing Catheter for AF Ablation - Impact of TactiCath on Dormant Conduction Across the Pulmonary Veins

FORMIDIBLE
Start date: July 2016
Phase: N/A
Study type: Observational

The purpose of this study is to collect information about the success rate of atrial fibrillation (AF) ablation procedures using the contact force data from the TactiCath Quartz ablation catheter.

NCT ID: NCT02663206 Withdrawn - Clinical trials for Esophageal Achalasia

Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders

Start date: September 2016
Phase: N/A
Study type: Interventional

To compare the efficacy of peroral endoscopic myotomy and Botulinum toxin injection in spastic esophageal disorders.

NCT ID: NCT02662634 Withdrawn - Clinical trials for Non-small Cell Lung Cancer (NSCLC)

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Start date: March 2016
Phase: Phase 2
Study type: Interventional

Feasibility and Safety study of autologous dendritic cell immunotherapy (AGS-003-LNG) in patients with resectable non-small cell lung cancer.

NCT ID: NCT02662296 Withdrawn - Clinical trials for Recurrent Small Lymphocytic Lymphoma

Ibrutinib or Idelalisib in Treating Patients With Persistent or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma After Donor Stem Cell Transplant

Start date: March 2016
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well ibrutinib or idelalisib works in treating patients with chronic lymphocytic leukemia, small lymphocytic lymphoma, or non-Hodgkin lymphoma that is persistent or has returned (relapsed) after donor stem cell transplant. Ibrutinib and idelalisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT02662140 Withdrawn - Conduct Disorder Clinical Trials

Mobile Health Solutions for Behavioral Skill Implementation Through Homework

Start date: January 2016
Phase: N/A
Study type: Interventional

The primary purpose of this study is to develop a mobile health (mHealth) application that will both advance theory in and clinical practice of homework (HW) implementation. The mobile health application will enhance the existing evidence informed curriculum of a Multiple Family Group model (called 4 Rs and 2 Ss for Strengthening Families Model) for families with children who have disruptive behavior disorders. This mobile application consists of two primary components that will support engagement and integration of the model's core concepts in family life. The first component focuses on delivering homework via a highly engaging, multiplayer, interactive, cooperative, and skill-building game platform aimed at improving the "Design" and "Do" process of homework.The second component focuses on targeting factors putatively related to poor HW implementation within the "Do" process.

NCT ID: NCT02662075 Withdrawn - Smoking Clinical Trials

Effect of Electronic Cigarettes on Platelets, Endothelium and Inflammation

Start date: April 2015
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the acute effects of electronic cigarette (e-cigarette) smoking on measurable biomarkers of platelet function, vascular endothelial function and inflammation in healthy active smokers. 10 healthy subjects, smokers, with no other medical conditions will be included in this study and measurements will be obtained at baseline and after smoking an e-cigarette. The study will contribute to the understanding of the effects of e-cigarettes on cardiovascular physiology, specifically establishing if the use of e-cigarettes increases platelet aggregation and platelet activation when compared to baseline in healthy active smokers, if the use of e-cigarettes decreases brachial artery flow-mediated dilation compared to baseline in healthy active smokers, and to determine the association between biomarkers of inflammation, platelet function, and vascular endothelial function before and after use of e-cigarettes.

NCT ID: NCT02661659 Withdrawn - Clinical trials for Malignant Pleural Mesothelioma (MPM)

A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line Chemotherapy

Start date: June 12, 2016
Phase: Phase 1
Study type: Interventional

A phase Ib study investigating the safety, the immunogenicity and the optimal administration frequency of the S-588210 5-peptide vaccine in MPM patients without progression after pemetrexed-based chemotherapy will be conducted. Additionally, to identify more accurate predictive biomarkers of response to S-588210, T-cell-receptor-sequencing (TCR) pre- and post-vaccination will be performed in blood samples of patients treated with the vaccine. Immunohistochemical analysis of the vaccine oncoantigens will also be correlated with induction of antigen-specific T-cell responses. Finally, to explore the infiltration of tumors with T-cells and the potential presence of an immunosuppressive tumor microenvironment, immunohistochemistry for immune checkpoints (including PDL1/PD1, CTLA4) and immune suppressive cell subsets (T-regs, macrophages) will be performed.

NCT ID: NCT02661347 Withdrawn - Schizophrenia Clinical Trials

Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of transcranial direct current stimulation (tDCS) for the treatment of auditory hallucinations in patients currently on risperidone treatment who are experiencing recent onset psychosis.